Pages that link to "Q33833912"
Jump to navigation
Jump to search
The following pages link to Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. (Q33833912):
Displaying 50 items.
- Evidence of IL-18 as a novel angiogenic mediator (Q24291472) (← links)
- Interferon-beta for treatment of rheumatoid arthritis? (Q24793971) (← links)
- Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature (Q24799893) (← links)
- Angiogenesis in the pathogenesis of inflammatory joint and lung diseases (Q24805418) (← links)
- αV integrins in angiogenesis and cancer (Q26851768) (← links)
- Key role of alpha(1)beta(1)-integrin in the activation of PI3-kinase-Akt by flow (shear stress) in resistance arteries (Q28576516) (← links)
- Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradation (Q30495730) (← links)
- 18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression (Q30497615) (← links)
- Recent data on the role for angiogenesis in rheumatoid arthritis (Q30882384) (← links)
- Inhibition of experimental choroidal neovascularization in rats by an alpha(v)-integrin antagonist (Q31103443) (← links)
- Angiogenesis: regulators and clinical applications (Q31923131) (← links)
- Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis (Q32044975) (← links)
- Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis (Q33437895) (← links)
- The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. (Q33606824) (← links)
- Evaluation of synovial angiogenesis in patients with rheumatoid arthritis using ⁶⁸Ga-PRGD2 PET/CT: a prospective proof-of-concept cohort study (Q33659257) (← links)
- A role for angiogenesis in rheumatoid arthritis (Q33690821) (← links)
- Extracellular matrix modulates angiogenesis in physiological and pathological conditions (Q33737210) (← links)
- Endothelial adhesion molecules in the development of the vascular tree: the garden of forking paths. (Q33744958) (← links)
- Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis? (Q33762520) (← links)
- New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders (Q33801264) (← links)
- Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts (Q33939357) (← links)
- Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis (Q33964836) (← links)
- Identification and in vivo efficacy of small-molecule antagonists of integrin alphavbeta3 (the vitronectin receptor). (Q33994755) (← links)
- Beneficial effects of integrin αvβ3-blocking RGD peptides in early but not late phase of experimental glomerulonephritis (Q34065809) (← links)
- The role of angiogenesis in rheumatoid arthritis: recent developments (Q34071300) (← links)
- Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response (Q34096563) (← links)
- Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases (Q34154425) (← links)
- Cellular interactions in vascular growth and differentiation (Q34177719) (← links)
- Rheumatoid arthritis. From bench to bedside (Q34275998) (← links)
- Potential biologic agents for treating rheumatoid arthritis (Q34276030) (← links)
- ECM remodeling regulates angiogenesis: endothelial integrins look for new ligands (Q34528233) (← links)
- Antagonising angiogenesis in rheumatoid arthritis (Q34560589) (← links)
- Synergistic Effect of Antiangiogenic Nanotherapy Combined with Methotrexate in The Treatment of Experimental Inflammatory Arthritis (Q34562028) (← links)
- Sickle red cell-endothelium interactions (Q34686539) (← links)
- Rheumatoid arthritis: developing pharmacological therapies (Q34706975) (← links)
- VEGF and imaging of vessels in rheumatoid arthritis (Q34731141) (← links)
- Osteoporosis in the rheumatic disease patient (Q34986976) (← links)
- Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases. (Q34989354) (← links)
- Development of vasculature targeting strategies for the treatment of cancer and chronic inflammatory diseases (Q35000516) (← links)
- Antagonizing the αv β3 integrin inhibits angiogenesis and impairs woven but not lamellar bone formation induced by mechanical loading. (Q35068663) (← links)
- Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis (Q35140465) (← links)
- The therapeutic potential of TNF-alpha blockade in rheumatoid arthritis (Q35164732) (← links)
- Magnetic resonance imaging, radiography, and scintigraphy of the finger joints: one year follow up of patients with early arthritis. The TIRA Group (Q35549474) (← links)
- Immunohistochemical localisation of protein tyrosine kinase receptors Tie-1 and Tie-2 in synovial tissue of rheumatoid arthritis: correlation with angiogenesis and synovial proliferation (Q35549523) (← links)
- Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha (Q35552325) (← links)
- Angiogenesis as a target in rheumatoid arthritis (Q35553507) (← links)
- Endothelial FAK as a therapeutic target in disease (Q35597214) (← links)
- Apoptotic cues from the extracellular matrix: regulators of angiogenesis (Q35603378) (← links)
- Regulation of α5 and αV Integrin Expression by GDF-5 and BMP-7 in Chondrocyte Differentiation and Osteoarthritis (Q35641534) (← links)
- Cooperation between VEGF and beta3 integrin during cardiac vascular development (Q35642757) (← links)